Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 4.949M
March 31, 2026 3.994M
December 31, 2025 4.459M
September 30, 2025 5.186M
June 30, 2025 4.671M
March 31, 2025 5.209M
December 31, 2024 5.755M
September 30, 2024 4.687M
June 30, 2024 4.167M
March 31, 2024 4.788M
December 31, 2023 4.697M
September 30, 2023 5.698M
June 30, 2023 6.181M
March 31, 2023 6.847M
December 31, 2022 7.637M
September 30, 2022 8.218M
Date Value
June 30, 2022 9.348M
March 31, 2022 10.30M
December 31, 2021 12.08M
September 30, 2021 0.484M
June 30, 2021 0.269M
March 31, 2021 1.00M
December 31, 2020 0.071M
September 30, 2020 0.374M
June 30, 2020 0.441M
March 31, 2020 0.556M
December 31, 2019 0.38M
September 30, 2019 0.188M
June 30, 2019
March 31, 2019
December 31, 2018 0.281M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 1.613B
Neogen Corp. 2.093B
QuidelOrtho Corp. 1.775B
Aspira Women's Health, Inc. -7.256M
Biomerica, Inc. 2.63M

Shareholders Equity (Quarterly) Related Metrics